Benjamin Wolozin
#107,054
Most Influential Person Now
American pharmacologist and neurologist
Benjamin Wolozin's AcademicInfluence.com Rankings
Benjamin Wolozinmedical Degrees
Medical
#2148
World Rank
#2550
Historical Rank
Pharmacology
#251
World Rank
#296
Historical Rank
Neurology
#236
World Rank
#314
Historical Rank
Download Badge
Medical
Benjamin Wolozin's Degrees
- Doctorate Medicine University of Pennsylvania
- PhD Pharmacology University of Pennsylvania
Why Is Benjamin Wolozin Influential?
(Suggest an Edit or Addition)According to Wikipedia, Benjamin Wolozin is an American pharmacologist and neurologist currently at Boston University School of Medicine and an Elected Fellow of the American Association for the Advancement of Science. Wolozin received his B.A. from Wesleyan University and his M.D., Ph.D. from the Albert Einstein College of Medicine. He is currently a professor of Pharmacology, Neurology and the Program in Neuroscience at Boston University School of Medicine. He is also co-founder and Chief Scientific Officer of Aquinnah Pharmaceuticals Inc., a biotechnology company developing novel therapeutics to treat Alzheimer's disease and Amyotrophic Lateral Sclerosis.
Benjamin Wolozin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein (1995) (2557)
- The spectrum of disease in chronic traumatic encephalopathy. (2013) (1695)
- Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. (2000) (1460)
- Protein Phase Separation: A New Phase in Cell Biology. (2018) (1096)
- Depletion of microglia and inhibition of exosome synthesis halt tau propagation (2015) (1008)
- Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model (2012) (817)
- CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation (2004) (652)
- Parkin Protects against the Toxicity Associated with Mutant α-Synuclein Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons (2002) (579)
- A neuronal antigen in the brains of Alzheimer patients. (1986) (564)
- Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin Transporter (1993) (541)
- Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue (2010) (539)
- α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins (1999) (499)
- Organization of the human serotonin transporter gene (2005) (490)
- Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later (2009) (486)
- The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity (2000) (453)
- Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation (1996) (451)
- Aggregated and Monomeric α-Synuclein Bind to the S6′ Proteasomal Protein and Inhibit Proteasomal Function* (2003) (428)
- Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. (1998) (409)
- Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis (2010) (371)
- Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease (2007) (357)
- Classification of multiple morphine and enkephalin binding sites in the central nervous system. (1981) (356)
- Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology (2003) (312)
- Stress granules and neurodegeneration (2019) (303)
- Regulated protein aggregation: stress granules and neurodegeneration (2012) (297)
- Local RNA Translation at the Synapse and in Disease (2011) (288)
- Cholesterol and the Biology of Alzheimer's Disease (2004) (272)
- Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of α-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans* (2005) (252)
- LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans (2009) (245)
- Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease* (2004) (242)
- Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. (2016) (224)
- Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. (1993) (217)
- alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. (1999) (213)
- The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. (2000) (203)
- Contrasting Pathology of the Stress Granule Proteins TIA-1 and G3BP in Tauopathies (2012) (188)
- A fluid connection: Cholesterol and Aβ (2001) (180)
- Alzheimer‐related neuronal protein A68: Specificity and distribution (1987) (174)
- Alz‐50 Antibody recognizes alzheimer‐related neuronal changes (1988) (173)
- Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein* (2002) (168)
- Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo (2017) (167)
- Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. (2005) (161)
- Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease (2005) (158)
- Direct association of presenilin‐1 with β‐catenin (1998) (151)
- Requirement of the Familial Alzheimer's Disease Gene PS2 for Apoptosis (1996) (139)
- Serum total cholesterol, statins and cognition in non-demented elderly (2009) (128)
- SEPT5_v2 is a parkin-binding protein. (2003) (128)
- Isolation of a cDNA encoding the human brain serotonin transporter (2005) (125)
- Leptin: a novel therapeutic strategy for Alzheimer's disease. (2009) (124)
- Primary structure of the serotonin transporter in unipolar depression and bipolar disorder (1995) (121)
- Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)* (2011) (120)
- α-Synuclein Interacts with Phospholipase D Isozymes and Inhibits Pervanadate-induced Phospholipase D Activation in Human Embryonic Kidney-293 Cells* (2002) (120)
- Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis (2016) (119)
- Longitudinal stability of CSF tau levels in Alzheimer patients (1999) (111)
- Role of Stress Granules and RNA-Binding Proteins in Neurodegeneration: A Mini-Review (2013) (109)
- The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation (2010) (101)
- MKK6 binds and regulates expression of Parkinson’s disease‐related protein LRRK2 (2010) (101)
- LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts (2016) (101)
- ALS-Linked Mutations Enlarge TDP-43-Enriched Neuronal RNA Granules in the Dendritic Arbor (2014) (101)
- Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. (1988) (101)
- Dysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders (2017) (99)
- Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. (2010) (96)
- Cholesterol, statins and dementia (2004) (95)
- Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. (2010) (91)
- Pathological stress granules in Alzheimer’s disease (2014) (91)
- Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein (2005) (90)
- Re‐assessing the relationship between cholesterol, statins and Alzheimer's disease (2006) (88)
- RNA binding proteins co-localize with small tau inclusions in tauopathy (2018) (86)
- Oxidative damage in the olfactory system in Alzheimer's disease (2003) (83)
- Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. (2002) (82)
- Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients (2004) (82)
- Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson's disease (2016) (78)
- Mechanisms of neurodegenerative disorders: Part 1: protein aggregates. (2000) (74)
- Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology (2018) (73)
- A fluid connection: cholesterol and Abeta. (2001) (71)
- Co-association of parkin and α-synuclein (2001) (67)
- Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative disease. (2014) (66)
- The heat shock transcription factor Hsf1 is downregulated in DNA damage–associated senescence, contributing to the maintenance of senescence phenotype (2012) (65)
- TIA1 regulates the generation and response to toxic tau oligomers (2018) (65)
- Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes (2017) (65)
- Book Review: Iron and Parkinson’s Disease (2002) (62)
- LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins (2010) (60)
- Regulation of Apoptosis by Presenilin 1 (1998) (59)
- Direct association of presenilin-1 with beta-catenin. (1998) (59)
- Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 (2020) (58)
- A High-Content Screen Identifies Novel Compounds That Inhibit Stress-Induced TDP-43 Cellular Aggregation and Associated Cytotoxicity (2014) (58)
- A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. (2014) (57)
- Physiological levels of β-amyloid increase tyrosine phosphorylation and cytosolic calcium (1995) (57)
- Olfactory neuroblasts from Alzheimer donors: Studies on APP processing and cell regulation (1993) (56)
- Parkin is metabolized by the ubiquitin/proteosome system (2000) (55)
- Pathological proteins in Parkinson’s disease (2007) (55)
- Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. (2005) (54)
- β-Synuclein Reduces Proteasomal Inhibition by α-Synuclein but Not γ-Synuclein* (2005) (53)
- FGF2 suppresses neuronogenesis of a cell line derived from rat olfactory epithelium. (1997) (52)
- The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. (2006) (51)
- Mutations in LRRK2 potentiate age-related impairment of autophagic flux (2015) (51)
- Watching worms whither: modeling neurodegeneration in C. elegans. (2011) (51)
- Regulation of Amyloid Precursor Protein Processing by Presenilin 1 (PS1) and PS2 in PS1 Knockout Cells* (2000) (50)
- TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau (2021) (49)
- Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease. (2003) (48)
- Investigating Convergent Actions of Genes Linked to Familial Parkinson’s Disease (2008) (47)
- Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. (1997) (46)
- alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. (2002) (45)
- Physiological levels of β-amyloid peptide promote PC12 cell proliferation (1996) (45)
- Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. (2012) (44)
- Mechanisms of neurodegenerative disorders: Part 2: control of cell death. (2000) (44)
- Regulation of Physiologic Actions of LRRK2: Focus on Autophagy (2011) (43)
- Induced Pluripotent Stem Cell Modeling of Multisystemic, Hereditary Transthyretin Amyloidosis (2013) (43)
- Differential effects of long-term lithium and carbamazepine administration on Gsα and Giα protein in rat brain (1991) (41)
- Cholesterol and Alzheimer's disease. (2002) (39)
- Dysregulation of RNA Splicing in Tauopathies (2019) (39)
- Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy. (2021) (38)
- Physiologic Levels of β‐Amyloid Activate Phosphatidylinositol 3‐Kinase with the Involvement of Tyrosine Phosphorylation (1996) (38)
- Physiological levels of β-amyloid peptide stimulate protein kinase C in PC12 cells (1997) (37)
- Presenilin 1 Regulates β-Catenin-mediated Transcription in a Glycogen Synthase Kinase-3-independent Fashion* (2001) (36)
- Human Olfactory Neuroepithelial Cells: Tyrosine Phosphorylation and Process Extension Are Increased by the Combination of IL-1β, IL-6, NGF, and bFGF (1996) (36)
- Co-association of parkin and alpha-synuclein. (2001) (35)
- Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice. (2013) (34)
- Continuous culture of neuronal cells from adult human olfactory epithelium (2008) (34)
- A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins (2019) (33)
- Interventions for heart disease and their effects on Alzheimer's disease (2006) (33)
- FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome. (1999) (33)
- BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain. (2020) (32)
- Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein (2008) (31)
- Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue (2011) (30)
- Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology (2018) (30)
- The binding of kappa- and sigma-opiates in rat brain (1982) (30)
- Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease (2017) (28)
- Interaction of LRRK2 with kinase and GTPase signaling cascades (2014) (28)
- Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression. (1992) (28)
- beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein. (2005) (27)
- Dioxins and related environmental contaminants increase TDP-43 levels (2017) (27)
- Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease? (2012) (26)
- Fluoxetine modulates G protein αs, αq and α12 subunit mRNA expression in rat brain (1992) (26)
- TDP-43: A new player on the AD field? (2012) (26)
- Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial (2017) (26)
- Physiological levels of beta-amyloid peptide promote PC12 cell proliferation. (1996) (26)
- Regulation of Autophagy by LRRK2 in Caenorhabditis elegans (2013) (24)
- RNA binding proteins and the genesis of neurodegenerative diseases. (2015) (23)
- Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy (2020) (21)
- Lipid-Lowering Treatment Is Related to Decreased Risk of Dementia: A Population-Based Study (FINRISK) (2010) (21)
- Hypoxia Enhances β-Amyloid-Induced Apoptosis in Rat cultured Hippocampal Neurons (2002) (21)
- Recent advances in the neurochemistry of Alzheimer's disease. (1987) (21)
- Differential expression of carboxyl terminal derivatives of amyloid precursor protein among cell lines (1992) (20)
- Monomeric C‐reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype‐dependent pattern: A risk factor for Alzheimer’s disease? (2021) (19)
- Changes in gene transcription during a beta-mediated cell death. (1996) (18)
- Simvastatin inhibits protein isoprenylation in the brain (2016) (18)
- The Pathophysiology of Tau and Stress Granules in Disease. (2019) (18)
- β-Amyloid augments platelet aggregation: reduced activity of familial angiopathy-associated mutants (1998) (16)
- Chronic traumatic encephalopathy (CTE) in blast-exposed U.S. military veterans and a new blast neurotrauma mouse model (2012) (15)
- P3-228 Chip and HSP70 regulate tau ubiquitination, degradation and aggregation (2004) (15)
- Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau (2018) (15)
- The unconscious in economic decision-making: Convergent voices (2007) (13)
- Direct sequencing of the reserpine‐sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness (1994) (13)
- Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo (2020) (13)
- Hypoxia enhances beta-amyloid-induced apoptosis in rat cultured hippocampal neurons. (2002) (13)
- Differential Regulation of APP Secretion by Apolipoprotein E3 and E4 a (1996) (13)
- The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation. (2020) (12)
- Following the leader: fibrillization of α-synuclein and tau (2004) (12)
- Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: Possible molecular basis for species differences in the susceptibility to MPP+ (2005) (12)
- Alzheimer’s disease: many failed trials, so where do we go from here? (2020) (12)
- Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 (2021) (11)
- Fluoxetine modulates G protein alpha s, alpha q, and alpha 12 subunit mRNA expression in rat brain. (1992) (11)
- The Evolution of Phase-Separated TDP-43 in Stress (2019) (11)
- Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury (2020) (11)
- Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association With RNA Binding Proteins (2020) (11)
- 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid decreases NMDA receptor mRNA. (1992) (10)
- Protein Interaction Network Biology in Neuroscience (2020) (10)
- The players on the γ-secretase team (2006) (10)
- β/A4 domain of APP: Antigenic differences between cell lines (1992) (10)
- Protein alterations in olfactory neuroblasts from Alzheimer donors (1994) (9)
- Statins and therapy of Alzheimer's disease: questions of efficacy versus trial design (2011) (8)
- 5’ UTR variants in the quantitative trait gene Hnrnph1 support reduced 5’ UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity (2020) (7)
- 5′ UTR variants in the quantitative trait gene Hnrnph1 support reduced 5′ UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity (2020) (7)
- Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial (2020) (7)
- Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation (2018) (6)
- O1-05-05: Use of angiotensin receptor blockers is associated with a lower incidence and progression of Alzheimer's disease (2008) (6)
- BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain. (2020) (6)
- Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brain. (1991) (6)
- Following the leader: fibrillization of alpha-synuclein and tau. (2004) (6)
- Effects of Amylin Against Amyloid-β-Induced Tauopathy and Synapse Loss in Primary Neurons. (2019) (5)
- Transforming growth factor beta induces a beta-responsive calcium fluxes in neurons. (1995) (5)
- 1 RAC 1 RESCUES NEURITE RETRACTION CAUSED BY G 2019 S LEUCINE-RICH REPEAT KINASE 2 ( LRRK 2 ) (2011) (4)
- AMYLIN RECEPTOR LIGANDS REDUCE THE PATHOLOGICAL CASCADE OF ALZHEIMER’S DISEASE (2017) (4)
- Specific chemical modification of the readily nitrated tyrosine of the RTEM β-lactamase and of bacillus cereus β-lactamase I (1982) (4)
- Apolipoprotein E receptor LR11: intersections between neurodegeneration and cholesterol metabolism. (2004) (4)
- Tau Biology (2019) (3)
- A neuronal antigen in the brains of Alzheimer patients (1987) (3)
- RNA Binding Proteins in Health and Disease (2017) (3)
- P2-253 Risk of Alzheimer's disease diagnosis following coronary artery bypass graft surgery versus percutaneous transluminal coronary angioplasty (2004) (3)
- Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model (2022) (2)
- Pathogenic LRRK 2 mutations do not alter gene expression in cell model systems or human brain tissue (2017) (2)
- MICROGLIAL EXOSOMES PROPAGATE TAU PROTEIN FROM THE ENTORHINAL CORTEX TO THE HIPPOCAMPUS: AN EARLY PATHOPHYSIOLOGY OF ALZHEIMER’S DISEASE (2016) (2)
- Correction: Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue (2011) (2)
- Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1 (2022) (2)
- ARCHIVES OF NEUROLOGY (2015) (2)
- The Scientist's Pledge. (2013) (2)
- Goldstein and a Blast Neurotrauma Mouse Model Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans (2)
- Oligomeric tau disrupts nuclear envelope via binding to lamin proteins and lamin B receptor (2021) (2)
- Macromolecular Connectivity Landscape of Mammalian Brain (2018) (1)
- Functional variants within the 5UTR support reduced exon usage as a molecular mechanism underlying the quantitative trait gene Hnrnph1 for reduced methamphetamine sensitivity (2020) (1)
- Single cell transcriptomic profiling of neurodegeneration mediated by tau in a novel 3D neuron‐astrocyte coculture model (2021) (1)
- Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease (2006) (1)
- Interaction of tau with the RNA-Binding Protein TIA 1 Regulates tau Pathophysiology and Toxicity Graphical (2019) (1)
- Molecular Mechanisms of Neurodegenerative Disorders (2003) (1)
- Peering into proteolysis with presenilins. (2001) (1)
- Single cell transcriptomic profiling of neurodegeneration mediated by tau propagation in a novel 3D neuron-astrocyte coculture model (2021) (1)
- Amylin’s effects against A β induced tauopathy and synapse loss in primary neurons (2019) (1)
- Regulated protein aggregation: stress granules and neurodegeneration (2012) (1)
- P4-077 Modulation of amyloid precursor protein-processing by oxysterol-binding protein (2006) (0)
- TAU-INDUCED NEURODEGENERATION IS MEDIATED BY RNA BINDING PROTEINS (2017) (0)
- STRESS GRANULE FORMATION AND NEURONAL DEATH (2018) (0)
- Review for "Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis" (2019) (0)
- Multimodal Monitoring of Human Brain Organoids Implanted in Mice Using Transparent Microelectrodes (2021) (0)
- Is CABG associated with an increased risk of neurocognitive degeneration (2005) (0)
- Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury (2020) (0)
- S3-02-06 Associations between medication usage and the incidence of Alzheimer disease: Effects observed for cardiovascular and immunomodulatory medications (2006) (0)
- Competition between distinct ApoE alleles and mCRP for the endothelial receptor CD31 differentially regulates neurovascular inflammation and Alzheimer’s disease pathology (2021) (0)
- Contents, Vol. 59, 2013 (2013) (0)
- P.1.g.001 Chronic stress triggers Tau pathology through autophagy inhibition and induction of stress granules (2017) (0)
- Immunochemical Approaches to the Diagnosis of Alzheimer Disease (2020) (0)
- The players on the gamma-secretase team. (2006) (0)
- Modeling and elucidating the pathobiology of blast-induced traumatic brain injury in the mouse (2013) (0)
- Mid-infrared Chemical Imaging of Intracellular Tau Fibrils using Fluorescence-guided Computational Photothermal Microscopy. (2023) (0)
- C. elegans models of Alzheimer's disease and Parkinson's disease: Systems biology identifies an interaction between tau and LRRK2 (2010) (0)
- Regulation of ribosomal function by oligomeric tau (2020) (0)
- Mechanisms of degeneration in Parkinson’s disease (2005) (0)
- Antigene, anticorps et methode diagnostique pour la maladie d'alzheimer (1995) (0)
- Viewing neurodegeneration beyond the tangle: The role of RNA binding proteins in Alzheimer's disease (2013) (0)
- G3BP protects against pathological tau and oligomeric Aβ42-induced neurotoxicity (2013) (0)
- ENVIRONMENTAL STRESS AND GLUCOCORTICOIDS TRIGGER AN HDAC6-DEPENDENT INDUCTION OF STRESS GRANULES AND TAU AGGREGATION: IMPLICATIONS FOR ALZHEIMER'S DISEASE (2016) (0)
- The physiology and pathophysiology of α-synuclein: A protein chaperone that aggregates (2000) (0)
- Transcript of Live Discussion: The Cell Cycle in Alzheimer's Disease: Let's Unite Around Division (2003) (0)
- Corrigendum to “Syk and ye shall find” [EBioMedicine 2 (11) (2015) 190-1591] (2016) (0)
- Western Blotting : A Guide to Current Methods Introductions (0)
- Interaction between microtubule-associated protein tau and RNA binding proteins stimulates tau misfolding and stress granule formation (2015) (0)
- Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology (2018) (0)
- MULTIDOMAIN LIFESTYLE INTERVENTION, TELOMERE LENGTH CHANGE AND COGNITION: THE FINGER TRIAL (2017) (0)
- Single cell transcriptomic profiling of tau pathophysiology in a novel 3D neural‐glial coculture model (2021) (0)
- Syk and Yea Shall Find (2015) (0)
- EFFECTS OF A MULTIDOMAIN LIFESTYLE INTERVENTION ON TELOMERE LENGTH: THE FINGER TRIAL (2018) (0)
- Pharmacoepidemiological Studies Using the Veterans Affairs Decision Support System (2011) (0)
- Mechanisms of alpha-Synuclein Aggregation and Toxicity (2003) (0)
- Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue (2012) (0)
- 2.315 Identification of potent small molecule inhibitors of alpha-synuclein aggregation in cell culture and by in vitro screening (2007) (0)
- Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo (2017) (0)
- Dissecting the Biochemical Pathways Mediated by Genes Implicated in Parkinson’s Disease: Induction of DJ-1 Expression in A30P α-Synuclein Mice (2008) (0)
- Stress granules: Viewing neurodegeneration beyond the tangle (2013) (0)
- Cacna2d2 is an hnRNP H target of the striatal mRNA targetome and regulates methamphetamine behavior (2022) (0)
- Patent Number : 45 Date of Patent : 5 , 134 , 062 Jul . 28 , 1992 and Cell Spreading Decrease in Fibroblasts from Aged and Alzheimer Donors ' (2017) (0)
- A Complex Containing HNRNPA2B1 and N6-methyladenosine Modified Transcripts Mediates Actions of Toxic Tau Oligomers (2020) (0)
- Volumetric bond-selective imaging and spectroscopic analysis of cellular Tau fibrils through a fluorescence-guided computational chemical microscope (Conference Presentation) (2023) (0)
- HNRNPA2B1 Mediates the Association of Oligomeric Tau with N 6-Methyladenosine and Neurodegeneration (2020) (0)
- P4-191 Differential expression of cholesterol 24-hydroxylase and cholesterol 27-hydroxylase in Alzheimer's disease (2004) (0)
- P3-423: LRRK2 regulates the stress response in C. elegans and mammalian cells (2008) (0)
- Bulk and single cell transcriptomic analysis of different dementia types in human hippocampus (2022) (0)
- ASSOCIATIONS OF LEUCOCYTE TELOMERE LENGTH WITH BRAIN MRI AND PIB-PET MEASURES: THE FINGER STUDY (2017) (0)
- Dioxins and related environmental contaminants increase TDP-43 levels (2017) (0)
- Disrupted in Dementia (2018) (0)
- ICE and apoptosis (1997) (0)
- NOVEL INSIGHTS OF TAU RNA-PROTEIN BIOLOGY IN THE PRECIPITATING ROLE OF CHRONIC STRESS ON ALZHEIMER’S DISEASE BRAIN PATHOLOGY (2019) (0)
- Viewing neurodegeneration beyond the tangle: The role of RNA binding proteins in Alzheimer's disease (2013) (0)
- Stress granules and Alzheimer's disease: Colocalization with tau pathology (2011) (0)
- RNA binding proteins co-localize with small tau inclusions in tauopathy (2018) (0)
- The methamphetamine-induced RNA targetome of hnRNP H in Hnrnph1 mutants showing reduced dopamine release and behavior (2021) (0)
- Interpreting Clinical Studies of Putative Therapeutics for Alzheimer's Disease: The Case of Statins and NSAIDs (2007) (0)
- Long-term use of angiotensin receptor blockers and risk of Alzheimer's disease in a cohort of patients with hypertension (2010) (0)
- A Complex Containing HNRNPA2B1 and N 6-Methyladenosine Modified Transcripts Mediates Actions of Toxic Tau Oligomers (2020) (0)
- Mutations in LRRK2 potentiate age-related impairment of autophagic flux (2015) (0)
- Impact and blast neurotrauma mouse models of chronic traumatic encephalopathy validated by human neuropathology (2013) (0)
- C. elegans models of Alzheimer's disease and Parkinson's disease: Systems biology identifies LRRK2 shared interaction networks (2010) (0)
- Single cell transcriptomic profiling of tauopathy in a novel 3D neuron-astrocyte coculture model (2022) (0)
- Methodes de traitement, de prevention et de reduction du risque d'apparition de la maladie d'alzheimer utilisant un inhibiteur de la hmg-coa reductase (1999) (0)
- Specific chemical modification of the readily nitrated tyrosine of the RTEM beta-lactamase and of bacillus cereus beta-lactamase I. The role of the tyrosine in beta-lactamase catalysis. (1982) (0)
- Front Cover: Protein Interaction Network Biology in Neuroscience (2021) (0)
- Corrigendum: Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes. (2018) (0)
- Accumulation of m6A exhibits stronger correlation with MAPT than β-amyloid pathology in an APPNL-G-F /MAPTP301S mouse model of Alzheimer’s disease (2023) (0)
- Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress (2023) (0)
- 15 Pharmacoepidemiological Studies Using the Veterans Affairs Decision Support System (2017) (0)
- LONG‐TERM ANTIDEPRESSANT DRUG TREATMENT DIFFERENTIALLY MODULATES G&agr; SUBUNIT mRNA AND PROTEIN EXPRESSION IN RAT BRAIN (1992) (0)
- Identification of circRNAs linked to Alzheimer’s disease and related dementias (2022) (0)
- PRESENILINS AND THEIR ROLE IN APOPTOSIS (1998) (0)
- S1-03-06 Reduced incidence of Alzheimer's disease among subjects exposed to general anesthesia in non-cardiac operations: a retrospective analysis (2004) (0)
This paper list is powered by the following services:
Other Resources About Benjamin Wolozin
What Schools Are Affiliated With Benjamin Wolozin?
Benjamin Wolozin is affiliated with the following schools:
